Brecanavir

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Brecanavir
Brecanavir.png
Systematic (IUPAC) name
[(3R,3aS,6aR)-2,3,3a,4,5,6a-Hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-(1,3-benzodioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate
Clinical data
Legal status
?
Identifiers
CAS number 313682-08-5 N
ATC code None
PubChem CID 5743186
ChemSpider 4675192 YesY
UNII E367I8C7FI YesY
ChEMBL CHEMBL206031 YesY
Chemical data
Formula C33H41N3O10S2 
Mol. mass 703.82
 N (what is this?)  (verify)

Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.[1]

On December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.[2]

References[edit]